Towards tuberculosis elimination: an action framework for low-incidence countries
- PMID: 25792630
- PMCID: PMC4391660
- DOI: 10.1183/09031936.00214014
Towards tuberculosis elimination: an action framework for low-incidence countries
Abstract
This paper describes an action framework for countries with low tuberculosis (TB) incidence (<100 TB cases per million population) that are striving for TB elimination. The framework sets out priority interventions required for these countries to progress first towards "pre-elimination" (<10 cases per million) and eventually the elimination of TB as a public health problem (less than one case per million). TB epidemiology in most low-incidence countries is characterised by a low rate of transmission in the general population, occasional outbreaks, a majority of TB cases generated from progression of latent TB infection (LTBI) rather than local transmission, concentration to certain vulnerable and hard-to-reach risk groups, and challenges posed by cross-border migration. Common health system challenges are that political commitment, funding, clinical expertise and general awareness of TB diminishes as TB incidence falls. The framework presents a tailored response to these challenges, grouped into eight priority action areas: 1) ensure political commitment, funding and stewardship for planning and essential services; 2) address the most vulnerable and hard-to-reach groups; 3) address special needs of migrants and cross-border issues; 4) undertake screening for active TB and LTBI in TB contacts and selected high-risk groups, and provide appropriate treatment; 5) optimise the prevention and care of drug-resistant TB; 6) ensure continued surveillance, programme monitoring and evaluation and case-based data management; 7) invest in research and new tools; and 8) support global TB prevention, care and control. The overall approach needs to be multisectorial, focusing on equitable access to high-quality diagnosis and care, and on addressing the social determinants of TB. Because of increasing globalisation and population mobility, the response needs to have both national and global dimensions.
The content of this work is ©the authors or their employers. Design and branding are ©ERS 2015.
Conflict of interest statement
Conflict of interest: Disclosures can be found alongside the online version of this article at
Figures





Comment in
-
Numbers needed to treat to prevent tuberculosis.Eur Respir J. 2015 Dec;46(6):1836-8. doi: 10.1183/13993003.01047-2015. Eur Respir J. 2015. PMID: 26621887 No abstract available.
-
Accelerating tuberculosis elimination in low-incidence settings: the role of genomics.Eur Respir J. 2015 Dec;46(6):1840-1. doi: 10.1183/13993003.00788-2015. Eur Respir J. 2015. PMID: 26621889 No abstract available.
-
Accelerating tuberculosis elimination in low-incidence settings: the role of genomics.Eur Respir J. 2015 Dec;46(6):1841-3. doi: 10.1183/13993003.01664-2015. Eur Respir J. 2015. PMID: 26621890 No abstract available.
-
End TB with precision treatment!Eur Respir J. 2016 Feb;47(2):680-2. doi: 10.1183/13993003.01285-2015. Eur Respir J. 2016. PMID: 26828056 No abstract available.
-
Cameroon's MDR-TB treatment programme jeopardised by cross-border migration.Eur Respir J. 2016 Feb;47(2):684-6. doi: 10.1183/13993003.01324-2015. Eur Respir J. 2016. PMID: 26828058 No abstract available.
-
Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration.Eur Respir J. 2016 Feb;47(2):686-8. doi: 10.1183/13993003.01597-2015. Eur Respir J. 2016. PMID: 26828059 No abstract available.
References
-
- World Health Organization. Global tuberculosis report 2014. WHO/HTM/TB/2014.08 Geneva, World Health Organization, 2014.
-
- Blasi F, Barnes PJ, Gaga M, et al. . Future directions for the ERS: presidential plans. Eur Respir J 2013; 42: 875–880. - PubMed
-
- Broekmans JF, Migliori GB, Rieder HL, et al. . European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002; 19: 765–775. - PubMed
-
- Lönnroth K, Jaramillo E, Williams BG, et al. . Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240–2246. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical